{
    "name": "vutrisiran",
    "comment": "Rx",
    "other_names": [
        "Amvuttra"
    ],
    "classes": [
        "RNAi Agents"
    ],
    "source": "https://reference.medscape.com/drug/amvuttra-vutrisiran-4000233",
    "pregnancy": {
        "common": [
            "Data regarding use in pregnant females are not available to inform of drug-associated risk of adverse developmental outcomes",
            "Vutrisiran leads to decreased serum vitamin A levels, and vitamin A supplementation is advised",
            "Vitamin A is essential for normal embryofetal development; however, excessive levels of vitamin A are associated with adverse developmental effects"
        ],
        "specific": [
            {
                "type": "Animal studies",
                "description": [
                    "SC administration to pregnant rats (up to 30 mg/kg/day) during organogenesis resulted in developmental toxicity (reduced fetal body weight and embryofetal mortality) at doses associated with maternal toxicity",
                    "SC administration (up to 20 mg/kg) to pregnant rats q6days throughout pregnancy and lactation resulted in no adverse developmental effects on the offspring"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Data are not available regarding presence in human milk, effects on breastfed infants, or effects on milk production",
            "Consider developmental and health benefits of breastfeeding along with the motherâ€™s clinical need for vutrisiran and any potential adverse effects on the breastfed infant from vutrisiran or from the underlying maternal condition "
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": [
                {
                    "type": "Vitamin A deficiency",
                    "description": [
                        "Decreases serum vitamin A levels",
                        "Supplement vitamin A at recommended daily allowance (RDA)",
                        "Do not give higher doses than RDA to try to achieve normal serum vitamin A levels during treatment, as serum vitamin A levels do not reflect the total vitamin A in the body",
                        "Refer patients to an ophthalmologist if ocular symptoms suggestive of vitamin A deficiency (eg, night blindness) develop "
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Arthralgia",
            "percent": "11"
        },
        {
            "name": "Dyspnea",
            "percent": "7"
        },
        {
            "name": "Vitamin A decreased",
            "percent": "7"
        },
        {
            "name": "Injection site reactions",
            "percent": "4"
        },
        {
            "name": "Atrioventricular heart block",
            "percent": "1.6"
        },
        {
            "name": "Pain in extremity",
            "percent": null
        },
        {
            "name": "Arthralgia",
            "percent": null
        },
        {
            "name": "Dyspnea",
            "percent": null
        },
        {
            "name": "Decreased vitamin A",
            "percent": null
        }
    ]
}